142 related articles for article (PubMed ID: 28197929)
1. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
2. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process.
Shi Y; Li W; Jia Q; Wu J; Wu S; Wu S
Exp Cell Res; 2024 Apr; 437(1):113996. PubMed ID: 38508327
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer.
Yang Z; Wang H; Xia L; Oyang L; Zhou Y; Zhang B; Chen X; Luo X; Liao Q; Liang J
J Cancer; 2017; 8(8):1484-1491. PubMed ID: 28638464
[No Abstract] [Full Text] [Related]
5. Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition.
Kapeleris J; Müller Bark J; Ranjit S; Richard D; Vela I; O'Byrne K; Punyadeera C
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3501-3510. PubMed ID: 35932303
[TBL] [Abstract][Full Text] [Related]
6. Genetically Engineered Lung Cancer Cells for Analyzing Epithelial-Mesenchymal Transition.
Kiełbus M; Czapiński J; Kałafut J; Woś J; Stepulak A; Rivero-Müller A
Cells; 2019 Dec; 8(12):. PubMed ID: 31847480
[TBL] [Abstract][Full Text] [Related]
7. A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.
Ginn L; Maltas J; Baker MJ; Chaturvedi A; Wilson L; Guilbert R; Amaral FMR; Priest L; Mole H; Blackhall F; Diamantopoulou Z; Somervaille TCP; Hurlstone A; Malliri A
Proc Natl Acad Sci U S A; 2023 Oct; 120(40):e2300489120. PubMed ID: 37748077
[TBL] [Abstract][Full Text] [Related]
8. Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition.
Kimura I; Kitahara H; Ooi K; Kato K; Noguchi N; Yoshizawa K; Nakamura H; Kawashiri S
Oncol Lett; 2016 Jan; 11(1):201-207. PubMed ID: 26870189
[TBL] [Abstract][Full Text] [Related]
9. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.
Ooi AT; Mah V; Nickerson DW; Gilbert JL; Ha VL; Hegab AE; Horvath S; Alavi M; Maresh EL; Chia D; Gower AC; Lenburg ME; Spira A; Solis LM; Wistuba II; Walser TC; Wallace WD; Dubinett SM; Goodglick L; Gomperts BN
Cancer Res; 2010 Aug; 70(16):6639-48. PubMed ID: 20710044
[TBL] [Abstract][Full Text] [Related]
10. The impact of vascular division sequence and epithelial-mesenchymal transition status on postoperative recurrence in lung adenocarcinoma.
Nishikawa S; Menju T; Takahashi K; Sowa T; Yoshizawa A; Date H
Asian Cardiovasc Thorac Ann; 2024 Mar; 32(2-3):123-132. PubMed ID: 38254290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of digital real-time PCR assay as a molecular diagnostic tool for single-cell analysis.
Chang CH; Mau-Hsu D; Chen KC; Wei CW; Chiu CY; Young TH
Sci Rep; 2018 Feb; 8(1):3432. PubMed ID: 29467444
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
13. Human lung epithelial cells A549 epithelial-mesenchymal transition induced by PVA/Collagen nanofiber.
Li X; Yan S; Dai J; Lu Y; Wang Y; Sun M; Gong J; Yao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():390-397. PubMed ID: 29245116
[TBL] [Abstract][Full Text] [Related]
14. Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma.
Fujii K; Nakamura H; Nishimura T
Expert Rev Proteomics; 2017 Apr; 14(4):373-386. PubMed ID: 28271730
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).
Chae YK; Chang S; Ko T; Anker J; Agte S; Iams W; Choi WM; Lee K; Cruz M
Sci Rep; 2018 Feb; 8(1):2918. PubMed ID: 29440769
[TBL] [Abstract][Full Text] [Related]
16. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease.
Jolly MK; Ward C; Eapen MS; Myers S; Hallgren O; Levine H; Sohal SS
Dev Dyn; 2018 Mar; 247(3):346-358. PubMed ID: 28646553
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Mesenchymal Transition in Tumor Metastasis.
Mittal V
Annu Rev Pathol; 2018 Jan; 13():395-412. PubMed ID: 29414248
[TBL] [Abstract][Full Text] [Related]
19. Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs.
Waryah C; Alves E; Mazzieri R; Dolcetti R; Thompson EW; Redfern A; Blancafort P
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370762
[TBL] [Abstract][Full Text] [Related]
20. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.
Thompson JC; Hwang WT; Davis C; Deshpande C; Jeffries S; Rajpurohit Y; Krishna V; Smirnov D; Verona R; Lorenzi MV; Langer CJ; Albelda SM
Lung Cancer; 2020 Jan; 139():1-8. PubMed ID: 31683225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
